Xylem Reports First Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Wall St futures gain as AI, consulting stocks offset bond-market jitters
- Oil prices rise 2% as China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Elevated equity positioning, leverage could challenge stocks in Q4: JPMorgan
- These 5 AI chip stocks are must-own into Q4, BofA says
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Goldman Sachs Upgrades Xylem (XYL) to Neutral
May 5, 2021 9:15 AM EDTGoldman Sachs analyst Brian Lee upgraded Xylem (NYSE: XYL) from Sell to Neutral with a price target of $107.00 (from $73.00).
The analyst comments "We acknowledge that our negative call here has been wrong, as we believed the company had more revenue downside risk... More
Xylem (XYL) Tops Q1 EPS by 10c, Revenues Beat; Raises FY21 EPS Guidance
May 4, 2021 6:57 AM EDTXylem (NYSE: XYL) reported Q1 EPS of $0.48, $0.10 better than the analyst estimate of $0.38. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.17 billion.
Our Xylem team performed exceptionally well in the first quarter, despite ongoing pandemic challenges around the world. Im so proud of how the team has served our customers... More
